Clinical Trial Update: Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the therapeutic effect of irinotecan liposomes in small cell lung cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Irinotecan liposome (liposomal irinotecan)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Small Cell Lung Cancer | Phase 4 | Status: RECRUITING